| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |